Liver Cancer News
2026
March
A Turn Toward Hope: How a Patient With Liver Cancer Found Lifesaving Options
Mercy St. Louis Uses Sci-Fi-Like Tech to Destroy Liver Tumors Without a Single Incision
A Machine Learning Model May Enable Liver Cancer Risk Prediction With Routine Clinical Information
Improving Early Detection And Treatment Of Liver Cancer
FDA Fast Track Status Advances PLT012 in HCC Care
HKUMed Discovers Expanded Use Of Fatty Liver Drug For Preventing And Suppressing Liver Cancer
Oncologist Warns Over 'Phantom Pain' That Is Red Flag Of Liver Cancer
Y90-Radioembolization Radiation Therapy For Liver Cancer Patients
Life After Liver Cancer: A Couple’s Journey of Recovery and Care
Life After Liver Cancer: A Couple’s Journey of Recovery and Care
A Promising Fatty Liver Treatment May Actually Trigger Cancer
Pancreatic, Bowel, And Liver Cancers Are On The Rise, Though Death Rates Are Down
Antibiotics Linked to Worse Outcomes in Patients With GI, Liver Cancer Receiving ICIs
Uncovering A Key Signaling Pathway Linking Liver Cancer And Fibros
How A Rare Pediatric Liver Cancer Emerges
Additional Radiation For Liver Cancer Does Not Increase Toxicity
Navigating Diagnostic Ambiguity and Histologic Uncertainty in HCC
Hepatocellular Carcinoma: Clinical Trials To Watch
Emerging MRI Scoring System May Bolster Risk Stratification for Early Recurrence of HCC
Additional Radiation For Liver Cancer Does Not Increase Toxicity
AI Liquid Biopsy Offers Early Detection Of Liver Disease
Breakthrough Reported In Liver Cancer Survival
Eating Less Protein May Slow Liver Cancer Growth, Study Finds
Wnt Signalling Associated with Aggressive Liver Cancer
Global Strategies To Reverse The Rise Of Liver Cancer
Systemic Therapy and Downstaging in Unresectable, Nonmetastatic HCC
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?
Delaying Treatment in HCC Does Not Affect Mortality at 6 Months
Dietary Protein as a Modifiable Risk Factor in Liver Cancer, With Wei-Xing Zong, PhD
Biosimilar-Backed Triplet Regimen Shows Feasibility in Heavily Pretreated Liver Cancer
February
Transplant Oncology Expands Liver Transplant Options
Biosimilar-Backed Triplet Regimen Shows Feasibility in Heavily Pretreated Liver Cancer
Pressure-Driven Pathway Links Liver Congestion to Fibrosis and Cancer
Biomarkers Indicating Higher Liver Cancer Risk In Chronic Hepatitis B Patients Identified
Evaluating The Clinical Utility Of MRI In Liver Cancer Planning And Simulation
iMBIs Support Patients With HCC, But Resistance to Mindfulness Practice May Persist
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
PLT012 Receives FDA Fast Track Designation for Liver Cancer Treatment
'I Thought I Had Indigestion - It Turned Out To Be Liver Cancer'
Machine-Learned Biomarker Identifies Those At High Risk For Liver Cancer
Researchers Develop New Score To Predict The Risk Of Liver Cancer
'Right Side' Symptom Could Be Sign Of 'Silent Killer' Cancer According To NHS
A Liver Cancer Journey Marked by Persistence, Family and Hope
FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer
Plasma Cell-Free DNA Methylation Analysis Is Highly Sensitive to Detecting Hepatocellular Carcinoma
From Missed Signs to Second Chances After a Liver Cancer Diagnosis
A Simple Diet Change Could Slow Liver Cancer
Liver Cancer Rates Start to Decline but Survival Gains Stalled During COVID
Abbreviated Hepatocellular Carcinoma MRI Protocols Have Many Benefits
Never Ignore These 12 Symptoms, Your Body Could Be Warning Of Liver Cancer
Key Oncology Drugs Granted FDA Designations in January 2026
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
January
Restricting Dietary Protein Could Prevent Liver Cancer Development in At-Risk Patients
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
Scientists Discover Potential New Cancer Treatment
HCC: LLM Advice and Treatment Concordance
AI Treatment Suggestions for Liver Cancer More Accurate at Early Stages
Atezolizumab Combo May Be Superior to TACE for Certain Liver Cancers
A Natural “Safety Switch” Protects the Liver as it Heals from Injury, Study Finds
Scientists Warn Of Hidden Cancer Risk In Popular Fatty Liver Treatment Strategy
Adjuvant Pembrolizumab Fails in Phase 3 Liver Cancer Trial
Atezolizumab Plus Bevacizumab Shows Potential Advantage Over TACE in Intermediate-Stage HCC
Your Liver May Already Be Changing Because Of What You Eat Every Day, Scientists Warn
Breaking Down Key Misconceptions in Hepatocellular Carcinoma Care
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026
For past liver cancer news, please visit our Liver Cancer News Archives.